| Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer CE Geyer Jr, JE Garber, RD Gelber, G Yothers, M Taboada, L Ross, ... Annals of oncology 33 (12), 1250-1268, 2022 | 180 | 2022 |
| Normal breast-derived epithelial cells with luminal and intrinsic subtype-enriched gene expression document interindividual differences in their differentiation cascade B Kumar, M Prasad, P Bhat-Nakshatri, M Anjanappa, M Kalra, N Marino, ... Cancer research 78 (17), 5107-5123, 2018 | 56 | 2018 |
| AB006. OS01. 06. Factors associated with survival in patients with thymoma: study of 523 cases from one institution H Zhang, W Wang, K Kesler, M Kalra, PJ Loehrer Mediastinum 1 (9), 2017 | 56 | 2017 |
| Cisplatin+/− rucaparib after preoperative chemotherapy in patients with triple-negative or BRCA mutated breast cancer M Kalra, Y Tong, DR Jones, T Walsh, MA Danso, CX Ma, P Silverman, ... NPJ breast cancer 7 (1), 29, 2021 | 16 | 2021 |
| Tracking the progression of triple negative mammary tumors over time by chemometric analysis of urinary volatile organic compounds M Woollam, L Wang, P Grocki, S Liu, AP Siegel, M Kalra, JV Goodpaster, ... Cancers 13 (6), 1462, 2021 | 14 | 2021 |
| High‐dose chemotherapy plus peripheral blood stem cell transplantation for patients with relapsed germ cell tumors and active brain metastases M Kalra, N Adra, N Hanna, R Abonour, LH Einhorn Cancer 126 (6), 1202-1207, 2020 | 10 | 2020 |
| Incorporating DNA methyltransferase inhibitors (DNMTis) in the treatment of genitourinary malignancies: a systematic review M Chovanec, F Taza, M Kalra, N Hahn, KP Nephew, MJ Spinella, ... Targeted oncology 13, 49-60, 2018 | 10 | 2018 |
| Survival outcomes of patients with metastatic germ cell tumor (mGCT) treated from 1998 to 2012: The Indiana University (IU) experience. N Adra, KP Ku, M Kalra, S Althouse, NH Hanna, LH Einhorn, C Albany Journal of Clinical Oncology 34 (2_suppl), 491-491, 2016 | 9 | 2016 |
| 654O Efficacy and safety of trastuzumab deruxtecan (T-DXd) in patients (pts) with solid tumors harboring specific HER2-activating mutations (HER2m): primary results from the … BT Li, F Meric-Bernstam, A Bardia, Y Naito, S Siena, PG Aftimos, ... Annals of Oncology 34, S459-S460, 2023 | 7 | 2023 |
| The effects of hypogonadism on quality of life in survivors of germ cell tumors treated with surgery alone versus surgery plus platinum-based chemotherapy N Khanal, SS Ahmed, M Kalra, TJ Miller, MJ Brames, TE Stump, ... Supportive Care in Cancer 28, 3165-3170, 2020 | 4 | 2020 |
| A phase 1b study of napabucasin (NAPA)+ weekly paclitaxel (PTX) in patients (pts) with advanced thymoma and thymic carcinoma. M Kalra, GM Cote, RS Heist, AJ Spittler, S Yu, M Hitron, PJ Loehrer Journal of Clinical Oncology 36 (15_suppl), e20578-e20578, 2018 | 4 | 2018 |
| Chemometric Analysis of Urinary Volatile Organic Compounds to Monitor the Efficacy of Pitavastatin Treatments on Mammary Tumor Progression over Time P Grocki, M Woollam, L Wang, S Liu, M Kalra, AP Siegel, BY Li, H Yokota, ... Molecules 27 (13), 4277, 2022 | 3 | 2022 |
| High-dose chemotherapy (HDCT) plus peripheral-blood stem-cell transplant (PBSCT) for patients (pts) with relapsed germ-cell tumors (GCT) and active brain metastases (mets). M Kalra, N Adra, J Mckay, R Abonour, NH Hanna, LH Einhorn Journal of Clinical Oncology 35 (15_suppl), 4558-4558, 2017 | 3 | 2017 |
| Dissemination of breast cancer knowledge and expertise from NCI-CCC tumor boards with community oncologists. M Kalra, MS Karuturi, RC Jankowitz, KE McCann, M Wei, SS Mougalian, ... Journal of Clinical Oncology 36 (15_suppl), e18575-e18575, 2018 | 2 | 2018 |
| Will PI3K-targeted therapies for cancer become a reality? M Kalra, H Nakshatri Translational Cancer Research 6 (Suppl 2), 2017 | 2 | 2017 |
| Proceedings of the 7th Biannual International Symposium on Nasopharyngeal Carcinoma 2015: Yogyakarta, Indonesia. 4-6 June 2015 IB Tan, ET Chang, CJ Chen, WL Hsu, YC Chien, A Hildesheim, JD McKay, ... BMC Proceedings 10, 1-24, 2016 | 2 | 2016 |
| Platelet Delta (δ)-Storage Pool Deficiency: A Case Series and Review of the Literature AF Beirat, SR Menakuru, M Kalra Hematology Reports 15 (3), 405-410, 2023 | 1 | 2023 |
| A Brief Report of a Phase II trial Evaluating Efficacy and Safety of Hypomethylating Agent Guadecitabine in Combination With Carboplatin in Extensive Stage Small Cell Lung Cancer CX Wei, H Mamdani, R Gentzler, M Kalra, S Perkins, S Althouse, SI Jalal Clinical lung cancer 24 (4), 347-352, 2023 | 1 | 2023 |
| Familial hypertrophic cardiomyopathy with fasciculoventricular accessory pathway V Kalra, K Akrawinthawong, M Kalra, R Jain Case Reports 4 (4), 198-204, 2022 | 1 | 2022 |
| A pilot study to assess the accuracy of “intuition” in analyzing post chemotherapy (chemo) residual retroperitoneal (RP) masses in patients (pts) with non seminomatous germ … C Cary, M Kalra, AG Menendez, TA Masterson, R Foster, LH Einhorn Journal of Clinical Oncology 36 (15_suppl), e16535-e16535, 2018 | 1 | 2018 |
